BMP receptor 1b is required for axon guidance and cell survival in the developing retina  by Liu, Janice et al.
BMP receptor 1b is required for axon guidance and cell survival
in the developing retina
Janice Liu,a,b Steven Wilson,b and Thomas Reha,b,*
a Department of Biological Structure, University of Washington, School of Medicine, Seattle, WA 98195, USA
b Department of Ophthalmology, University of Washington, School of Medicine, Seattle, WA 98195, USA
Received for publication 8 July 2002, revised 5 December 2002, accepted 5 December 2002
Abstract
Previous work has documented the importance of BMPs in eye development. Loss-of-function studies in mice, with targeted deletions
in either the Bmp7 or Bmp4 genes, have shown that these molecules are critical for early eye development. On the basis of the asymmetry
in the dorsal–ventral expression patterns of several members of this family, it has been proposed that these molecules are critical for some
aspect of dorsal–ventral patterning in the eye; however, it has been difficult to test this hypothesis because of the early requirement for BMPs
in eye development. We have therefore examined the effects of loss of one of the BMP receptors, the BmprIb, on the development of the
eye by using targeted deletion. We have found that BmprIb is expressed exclusively in the ventral retina during embryonic development and
is required for normal ventral ganglion cell axon targeting to the optic nerve head. In mice with a targeted deletion of the BmprIb gene, many
axons arising from the ventrally located ganglion cells fail to enter the optic nerve head, and instead, make abrupt turns in this region. A
second phenotype in these mice is a significantly elevated inner retinal apoptosis during a distinct phase of postnatal development, at the
end of neurogenesis. Our results therefore show two distinct requirements for BmprIb in mammalian retinal development.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
The development of the vertebrate eye is known to in-
volve many different tissue interactions and signaling
events. Recent studies have begun to identify some of the
factors that are involved in these interactions. For example,
interactions between the lens placode and the optic vesicle
can be mimicked by FGFs. Sonic Hedgehog expressed in
the presomitic mesoderm represses the “eye-field” at the
midline, allowing for the development of the paired eyes
(see Hartenstein and Reh, 2002, for review). An activin-like
molecule can replace a critical interaction between the mes-
enchyme and the optic vesicle that is required for the de-
velopment of the pigmented epithelium (Fuhrmann et al,
2000). Other studies have focused on other members of the
TGF family of factors, the BMPs. These factors are known
to play multiple roles during nervous system development,
including stimulating proliferation, dorsal-ventral pattern-
ing, triggering apoptosis, promoting neuronal survival, and
stimulating dendritic growth (Altmann and Brivanlou,
2001; Knecht and Harland, 1997; Mehler et al., 1997; Pan-
chision et al., 2001; Smith and Graham, 2001; Hogan,
1996).
The dynamic patterns of expression of BMPs during eye
development have led many to propose that these factors
have critical functions in the patterning of the ocular do-
mains. Both Bmp4 and Bmp7 are expressed early in the
developing eye. In both the chick and mouse embryos,
Bmp4 is first seen in the distal part of the optic vesicle and
the overlying surface ectoderm but then becomes restricted
to the dorsal margin of the optic vesicle by E9.5 (Belecky-
Adams and Adler, 2001; Dudley and Robertson, 1997; Fu-
ruta and Hogan, 1998; Lyons et al., 1995; Trousse et al.,
2001; Wawersik et al., 1999). The expression of Bmp7,
however, shows some differences between the chick and the
mouse. In the chick, Bmp7 is not expressed in the eye at the
optic vesicle stage but is instead first detected at the optic
* Corresponding author. Department of Biological Structure, Box
357420 Health Sciences Center, University of Washington, School of
Medicine, Seattle, WA 98195, USA . Fax: 1-206-543-1524.
E-mail address: tomreh@u.washington.edu (T. Reh).
R
Available online at www.sciencedirect.com
Developmental Biology 256 (2003) 34–47 www.elsevier.com/locate/ydbio
0012-1606/03/$ – see front matter © 2003 Elsevier Science (USA). All rights reserved.
doi:10.1016/S0012-1606(02)00115-X
cup stage. This expression is primarily confined to the
developing pigmented epithelium (Trousse et al, 2001).
Bmp2, -4, -5, -6, and -7, as well as their receptors, have all
been localized during retinal development (Belecky-Adams
and Adler, 2001). Many of these factors show distinct dor-
soventral differences in expression, and in general, the re-
ceptors are expressed in the ventral retina, while many of
the factors have higher levels of expression in the dorsal
retina. These regional expression patterns have led to spec-
ulation that BMPs are involved in the patterning of the
dorsoventral axis of the eye and/or the retina.
The functional analysis of BMPs in eye development has
been more complex, possibly because of the many different
functions of these molecules (Solursh et al., 1996). For
example, treatment of developing ocular tissues with BMPs
delivered on beads (Trousse et al., 2001) or with retrovi-
ruses (Adler and Belecky-Adams, 2002) has shown that
these factors can have a variety of effects on the develop-
ment of the eye, including the induction of apoptosis (Hung
et al., 2002), and the transformation of ventral pigmented
epithelium into neural retina. Loss-of-function studies in
mice, with targeted deletions in either Bmp7 or Bmp4, have
also shown that these molecules are critical for eye devel-
opment. For example, Bmp7 knockout mice frequently have
extreme defects in early eye development, even to the point
of being eyeless (Luo et al., 1995). Bmp4 knock-out mice
die early in embryonic development, but using explant cul-
tures of the head, Furuta and Hogan (1998) have found that
BMP4 is necessary for lens formation. Despite the clear
implication that BMPs play critical roles in eye develop-
ment, it has been difficult to identify the specific events
regulated by BMPs because of the extensive defects in the
knock-out animals. In addition, while the clear dorsal–ven-
tral differences in Bmp expression have been emphasized by
several investigators, the loss-of-function analyses have not
led to identification of dorsal–ventral patterning defects,
again likely because of the embryonic lethality (Bmp4-
deficient mice) or the failure of eye formation (Bmp7-defi-
cient mice).
On the other hand, there have been no reported loss-of-
function analyses of the functions of the BMP receptors on
eye development. The TGF family of signaling molecules
function by binding to and assembling a receptor complex
made up of a type I and a type II receptor. The type II
receptor activates the type I receptor, which then phosphor-
ylates one of several Smad proteins. The phospho-Smad can
then dimerize with a co-Smad and the complex enters the
nucleus to activate transcription of specific target genes
(Itoh et al., 2000). For the BMPs, the specific BMP recep-
tors are known as BmprIa (ALK3) and BmprIb (ALK6).
Each of these type I receptors can form a complex with a
type II receptor and phosphorylate Smad 1, 5, or 8. The
Smad proteins can act as transcriptional regulators to con-
trol expression of specific downstream target genes (Kawa-
bata et al., 1998; Massague, 1998; Massague and Chen,
2000). Since there is some redundancy in the reception of
the BMP signal, animals deficient in either the BmprIa or
BmprIb gene are viable, though they have defects in some of
the tissues known to require BMP during development.
Thus, we have analyzed animals deficient in BmprIb, a
receptor that is highly localized to ventral retina during
development, to determine the role of BMP signaling in
patterning the dorsal–ventral axis of the retina. We have
found that, although the overall patterning of the dorsal–
ventral axis of the retina appears to be normal in the Bm-
prIb/ mice, BmprIb is required for a population of ven-
trally arising ganglion cell axons to properly exit from the
retina at the optic nerve head. In addition, mice lacking the
BmprIb have a significantly elevated apoptosis during a
distinct phase of postnatal development, at the end of neu-
rogenesis. We discuss these findings in the context of the




The generation and initial characterization of BmprIb-
deficient mice were previously described (Yi et al., 2000).
BmprIb/ homozygous mice were genotyped by reverse
transcriptase polymerase chain reaction (RT-PCR) with the
forward primer 5-GGC TGA ATC ACA ACC ATT
TGG-3 and the reverse primer 5-GGG TGG AGG TCT
TTA TTA CAC-3 (Yi et al., 2000) and with mouse brain or
mouse tail total RNA prepared using TRIzoL reagent fol-
lowing the manufacturer’s protocol (Gibco, Grand Island,
NY).
Cloning of cDNA fragments for synthesis of RNA probe
Several of the clones used in this study were obtained by
PCR cloning from Balb/C mice. Total cellular RNA was
isolated from Balb/C mouse liver or brain (Jackson Lab,
NIH, Bethesda, MD). Five micrograms of total RNA were
used to synthesize cDNA at 42°C for 1 h with M-MLV
reverse transcriptase and random primers (Promega, Madi-
son, WI). The resulting cDNA was used for PCR. The
primers were designed according to the published sequences
of human or mouse genes. The PCR products were cloned
into pCRII TA cloning vector (Invitrogen, San Diego, CA)
and sequenced by using dideoxy sequencing method (Am-
ersham, Piscataway, NJ) to confirm the correction of cloned
PCR products. For synthesis of sense- and anti-sense probes
uniformly using T7 RNA polymerase, we subcloned the
cDNAs into pBluescript SK vector (Stratagene, La Jolla,
CA). The sequences used for PCR for the various transcripts
examined in this study are listed in Table 1.
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Synthesis of ribonucleic acid probes
Vectors were linearized at 37°C for 4 h by using HindIII
or XbaI restriction enzyme (Promega). One microgram of
the linearized cDNA was used to prepare sense or anti-sense
probes in a total 12.5 l of reaction solution with 5 l of
35S-UTP (1250 Ci/mmol, NEN, Boston, MA). The RNA
probes were extracted with phenol:chloroform:isoamyl al-
cohol, precipitated twice with 75% ethanol containing 10
mM of dithiothretol (DTT) and 0.5 M of ammonium ace-
tate, and washed with 75% ethanol containing 10 mM of
DTT and 25 mM of sodium acetate. The purified RNA
probes were dried in air for 20 min, dissolved in hybridiza-
tion buffer (pH 7.4, 0.3 M NaCl, 10 mM Tris, 5 mM EDTA,
10 mM Na2HPO4, 50% formamide, 200 mg/ml yeast tRNA,
10 mM DTT, 10% dextran sulfate, and 1  Denhardt’s
solution; Sigma), and denatured at 85°C for 5 min.
Paraffin and frozen sectioning
Paraffin sectioning is based on the method in Current
Protocols in Molecular Biology (Ausubel et al., 1991).
Briefly, Balb/C mouse embryos or heads from stages E9 to
E15 were fixed in freshly prepared 4% paraformaldehyde in
PBS (pH 7.3, 0.13 mM NaCl, 5 mM Na2HPO4, and 5 mM
NaH2PO4) at 4°C overnight, and mouse heads or eyes from
stages E18 to P10 were fixed in 10% neutral buffered
formalin (Sigma) at room temperature overnight. The tis-
sues were dehydrated in series of ethanols, cleared three
times in xylene, and embedded in paraffin wax. Seven
micrometers of sections were used for in situ hybridization
and TUNEL assays. For the frozen sectioning, mouse eyes
were embedded in OCT (Sakura Finetek, Torrance, CA),
and 10-m sections were cut for histology and immuno-
staining analysis.
In situ hybridization
All chemicals used were purchased from Sigma. The
paraffin sections were deparaffinized in xylene, rehydrated,
digested with 20 g/ml of proteinase K at room temperature
for 8 min, and postfixed in 4% paraformaldehyde in PBS for
5 min. The sections were then washed with triethanol-
amine–hydrochloric acid buffer (pH 8.0, TEA–HCl) for 3
min and blocked with 0.25% and 0.5% acetic anhydride in
TEA–HCl buffer for 5 min, respectively. The blocked sec-
tions were washed with 2 SSC (pH 7.0, 0.3 M NaCl, and
0.03 M sodium citrate) for 5 min and dehydrated through an
ethanol series. The sections were dried in a hood for 1 h, and
40 l of 35S-labeled sense or anti-sense RNA probes (1 
106 CPM/l) was applied to the sections, which were then
covered with a coverslip and incubated in a humidified box at
50°C overnight. The coverslips were removed in 5 SSC at
60°C. The sections were washed with 50% formamide in 2
SSC and 20 mM 2-mercaptoethanol (ME) at 60°C for 1 h. The
sections were incubated with 10 mg/ml of RNase A at 37°C for
45 min. The RNase digested sections were washed sequen-
tially at 55°C once in 50% formamide in 2 SSC and 20 mM
ME for 1 h, twice in 2 SSC and 20 mM ME for 30 min, twice
in 0.1 SSC and 20 mM ME for 30 min, and then washed
once in 0.1 SSC and 20 mM ME at room temperature for 10
min. The sections were dehydrated gradually and air dried
Table 1
Gene name Forward primer Reverse primer Length (bp)
BMP 4 5-GAATGCTGATGGTCGTTT-3 5-CTTCTGCTGGGGGCTTCATAA-3 551
BMPR IA 5-GGACATTGCTTTGCCATCATA-3 5-CAGACCCACTACCAGAACTTT-3 424
BMPR IB 5-GTTGTAAATGCCACCACCACT-3 5-GTCGGGCTTCTTGTCTTTTAT-3 377
BMPR II 5-TGGCTGAACTTATGATGATTT-3 5-TGTTGGTGGAGAGGCTGGTGA-3 333
Ephrin A2 5-GCCTGCCACTCAAGGTTTATGTG-3 5-TCCCAGTGTCACCAGCAATGTC-3 463
Ephrin A5 5-TGTGTGTGTTCAGCCAGGACCC-3 5-TGTCAAAAGCATCGCCAGGAGG-3 554
Ephrin B1 5-CCAAGCAAGGAGTCAGACAACAC-3 5-TGGACGATGTAGACAGGATGCC-3 452
Ephrin B2 5-CAACTGTGCCAGACCAGACCAAG-3 5-CTGTGGAGAGTGTTTGCGGTGTC-3 490
Ephrin B3 5-TAGGTTTTGCGGGGCTGGTATC-3 5-GCATTTCAGACACAGGTTTTCGG-3 498
Eph B2 5-ATGGACTCTACGACAGCAACGG-3 5-CGCACAGCAATGAGGGACATAC-3 503
Eph B3 5-TCGTGGTCATCGCTCTTGTCTG-3 5-CCGTGAACTGTCCGTCATTGAG-3 474
Brn 3b 5-GAGGAAGCAGAGAAATCCCACC-3 5-TCTTGAGATCCAGCTTCTCGGC-3 186
FGF 15 5-CCCAGCAATCCCAGTCTGTGTC-3 5-CATCCTCCACCATCCTGAACGG-3 534
Math 5 5-GCCAGGACAAGAAGCTGTCCAAG-3 5-CTGGAAGCCGAAGAGCCTCTG-3 199
Pax 6 5-CTGAGGAACCAGAGAAGACAGGC-3 5-TGTGCGGAGGGGTGTAGGTATC-3 319
Netrin 1 5-AAAGCCTGTGATTGCCACCCAG-3 5-CTTGTCTGCCACGATGCCACTC-3 519
Zic 2 5-CCCTGGTGCCTTTTTCCGCTAC-3 5-TTCTTCCTGTCGCTGCTGTTGG-3 429
Chx 10 5-GAAGCGTAAGAAGCGGCGACAC-3 5-ACAGTCCCCGAGACCTTGGTGC-3 540
Vax 2 5-ACTTCCTTCACAGCAGAGCAGC-3 5-GAGTTTCTGGGGTCAACCAAGG-3 356
Tbx 5 5-AGGAGCACAGTGAGGCACAAAG-3 5-GAGGTGAAATGAGCGGAGAAGTG-3 518
Slit 2 5-ACAGTGGCACCAGGAGCATTTG-3 5-TGGAGGGATACATCTCAGACGG-3 525
C/EBP 1 5-AGAATGGCTTCTCCCTGGAGGAG-3 5-ACTTGGACACGACATCTGGAGGC-3 493
Mag 5-TGTCGCTGCTACACTTCGTGCC-3 5-AAGATGGTAAGGATGGGGTCCG-3 484
Gapdh 5-ACCACAGTCCATGCCATCAC-3 5-AGGTTCACCCTGTTGCTGTA-3 452
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for more than 2 h. The sections were coated with 1:1 diluted
Kodak NTB-2 autoradiographic emulsion (Rochester, NY)
and developed after exposure at 4°C for 6 or 7 days. The
sections were counterstained by using hematoxylin.
TUNEL assay
Paraffin sections were deparaffinized and rehydrated
described as above. The sections were washed twice with
PBS (pH 7.3, NaCl 137 mM, KCl 2.7 mM, Na2HPO4 4.3
mM, KH2PO4 1.4 mM) for 5 min, digested with 20 g/ml
of proteinase K in PBS at room temperature for 15 min,
and washed twice again with PBS for 5 min. The sections
were equilibrated with terminal dioxynucleotidyl trans-
ferase buffer (TdT buffer; Promega) at room temperature
for 15 min and incubated in TdT buffer containing 10
nmol/ml Cy3-dUTP (Amersham) and 500 /ml TdT at
37°C for 1 h. The reaction was stopped with 20 SSC at
room temperature for 15 min. The sections were washed
three times with PBS for 5 min and covered with fluoro-
Fig. 1. BMPR expression in the embryonic eye. (A–C) BmprIa expression in the dorsal and ventral hemiretinas. (M) A higher magnification view of panel
(C) shows that the expression is highest in the neuroblastic layer, where proliferating progenitor cells are found, and there is less expression in the ganglion
cell layer (GC). (D–F) BmprIb is primarily localized to the ventral retina at all embryonic ages. (D) At embryonic day 9, the expression is localized to a small
patch in the optic vesicle (arrow; OV). (E) At embryonic day 12, the expression is highest in the optic stalk (arrowhead) and in the ventral part of the optic
cup (arrow; OC). (F) AT E15, the expression of BmprIb is distinct in the ventral retina (arrow). (N) A higher magnification view of (F) shows that the
expression is highest in the neuroblastic layer, where proliferating progenitor cells are found, and there is little or no expression in the ganglion cell layer.
(G–I, O) BmprII expression is barely detectable prior to E15; at this age, the gene is expressed throughout the retina, though at a somewhat higher level in
the ganglion cell layer (O). BMPRII does not appear to show the dorsal ventral gradient in expression of BmprIb. (J–L, P) Bmp4 is expressed in the embryonic
retina and ciliary body. At E9, Bmp4 (J) is expressed primarily in the distal optic vesicle, and then E15 (L) becomes concentrated to the presumptive ciliary
body (CB), with lower levels of expression in the ganglion cell layer (P). All panels, dorsal is to the top; OV, optic vesicle; GC, ganglion cell layer; NB,
neuroblastic layer.
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mount-G (Southern Biotechnology Associates, Inc., Bir-
mingham, AL).
Dil labeling of retinal ganglion cells
Dil labeling of retinal ganglion cells was based on the
published method (Birgbauer et al., 2000). Mouse embry-
onic eyes at E15.5–E16.5 were dissected under the micro-
scope to remove the cornea, retinal pigmented epithelium,
and lens, and the retinas were flatmounted in 4% parafor-
maldehyde in PBS. The Dil paste (Molecular Probes, Eu-
gene, OR) was spotted into the ventral or dorsal retinas by
using an end-sharpened micropipet, and the retinas were
incubated in 4% paraformaldehyde in PBS at 37°C over-
night.
Immunostaining
Nonfixed or 4% paraformaldehyde fixed frozen sections
were incubated with primary antibody in PBS containing
5% goat serum and 0.1% Triton X-100 at 4°C overnight.
The sections were washed four times with PBS for 5 min.
The sections were incubated with AlexaFluor-conjugated
secondary antibody in PBS containing 5% goat serum and
0.1% Triton X-100 at room temperature for 2 h, washed
four times with PBS for 5 min, and then covered with
fluoromount.
Coimmuno- and DNA fragmentation staining
After the primary antibody immunostaining was per-
formed as described above, the sections were washed four
times with PBS for 5 min. The sections were incubated in
10% neutral buffed formalin at room temperature for 10
min, in a mixture of 50% methanol and 50% acetic acid at
20°C for 5 min, and then washed four times with PBS for
5 min. The sections were equilibrated with terminal di-
oxynucleotidyl transferase buffer, and the TUNEL assay
was performed as described above.
Results
The expression of BMP receptors and BMP4 during
mouse eye development
The expression of the BMP receptors has been previ-
ously reported; however, there has not been a systematic
description of the expression in the developing mouse eye
throughout embryonic development. Therefore, we describe
here the expression patterns for BmprIa (ALK3), BmprIb
(ALK6), and BmprII. We have specifically examined their
expression pattern along the dorsal–ventral axis in the
mouse eye, since previous reports in chick embryos have
indicated distinct dorsoventral patterns in expression. Fig. 1
shows the expression of these genes at embryonic days 9,
12, and 15, oriented with the dorsal side at the top of the
figure in all panels. In Fig. A–C and M, BmprIa is shown.
This gene is initially expressed at low levels in the optic
vesicle at E9; the levels increase by E12 (Fig. 1B), and there
does not appear to be any distinct dorsal–ventral gradient to
the expression. At E15, the gene is primarily expressed in
the neuroblastic layer (NB) and to a lesser degree in the
ganglion cell layer (Fig. 1C and M).
BmprIb, by contrast, has a much more highly polarized
expression pattern. The gene is expressed in a small patch of
the optic vesicle at E9 (Fig. 1D), and as early as E12 (Fig.
1E), this gene is expressed predominantly in the ventral part
of the optic vesicle (Fig. 1E; arrow) and the optic stalk (Fig.
1E; arrowhead). This predominantly ventral localization in
expression continues throughout embryonic development
(E15 shown in Fig. 1F, and higher power in Fig. 1N). As
can be seen in Fig. 1N, the expression of the BmprIb is
predominantly in the neuroblastic (NB) layer of the retina,
rather than in the differentiating ganglion cells.
BMPRII has an overall lower level of expression at the
early stages of development and is barely detectable by E12
(Fig. 1G and H). The levels of expression are significantly
higher at E15 (Fig. 1I). While BMPRII is needed as a
coreceptor for activation with either the BMPRIa or BM-
PRIb, the BmprII gene is expressed most highly in the
ganglion cell layer (Fig. 1I and O); however, the type I
receptors are expressed most highly in the neuroblastic layer
(compare Fig. 1F with I, or N with O).
In addition to the expression pattern of the BMP recep-
tors, we have also analyzed the expression of two of the
ligands for these receptors, Bmp4 and Bmp7. Of the two
genes, Bmp4 is more highly expressed in the embryonic
mouse eye, and so its expression was further analyzed. Fig.
1J–L and P shows the expression of Bmp4 in embryonic
stages of eye development. Bmp4 is highly expressed in the
distal part of the optic vesicle at E9 (Fig. 1J) and the
margins of the retina and developing ciliary body (CB) at
older embryonic ages (Fig. 1L and P). In addition, at E15,
there appears to be a low level of expression in the retinal
ganglion cell layer (Fig. 1L and P). These results thus
support the possibility that BMP-receptor interactions can
occur at embryonic stages of retinal development. Specifi-
cally, there may be paracrine signaling between ganglion
cells, as the source of the BMP signal, and the neuroblastic
layer cells, as the cells with the highest receptor expression.
However, given that there is also a low level of expression
of BmprIa and BmprII in the ganglion cells, we cannot rule
out that an autocrine signal is also important in this system.
We also examined the expression of these genes in mice
during the stages of postnatal retinogenesis. We found that
Bmp4 and all three of the BMP receptors are expressed
throughout the first postnatal week (Fig. 2). Bmp4 is ex-
pressed in both the dorsal and ventral ciliary body through-
out the first postnatal week (Fig. 2A and B). In addition,
Bmp4 is expressed in both the ganglion cell layer and the
amacrine cell layer of the INL (Fig. 2E). At P7, Bmp4 is also
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expressed throughout the INL (Fig. 2B, lower panel). Bm-
prIb, by contrast, is expressed more highly in the ventral
retina at P0, similarly to its ventrally localized expression in
the embryonic retina (Fig. 2C). However, this pattern shifts
over the next few days, and by P7, BmprIb is expressed as
highly in the dorsal retina as it is in the ventral retina (Fig.
2D, upper and lower panels, respectively). The other im-
portant feature about the expression pattern is that the grains
are concentrated over the inner nuclear layer in a band that
corresponds to the middle of the INL (Fig. 2D and F,
arrows). BmprII has an expression pattern that is, in some
ways, a combination of the two type I receptors, in that it is
expressed in the ganglion cell layer and both the presump-
tive amacrine cells, as well as in the middle of the INL (Fig.
2G). While we cannot directly demonstrate from the radio-
active in situ data that the type I and type II receptors are
expressed in the same cells, the patterns of expression are
consistent with this possibility.
BmprIb is necessary for retinal ganglion cell axonal
targeting through the optic nerve head
The striking dorsal–ventral gradient of BmprIb expres-
sion has led several investigators to suggest that this recep-
tor may be important in the establishment of dorsal–ventral
identity for the retinal ganglion cells. Previous work involv-
ing misexpression of BMPs or their antagonists in chick
embryos has lent support to this possibility (Adler and
Belecky-Adams, 2002; Trousse et al., 2001). In addition,
BMP signaling has also been implicated in regulation of
axon guidance (Augsburger et al., 1999). Since the BmprIb
gene is expressed highly and specifically in the ventral
retina during embryonic stages of eye development, we
examined mice deficient in BmprIb for defects in the growth
of axons from the ventral retina. We labeled small numbers
of ganglion cell axons by placing crystals of DiI onto the
surface of fixed flattened retinas, as shown in Fig. 3A. The
DiI diffuses from the source along the axons of the ganglion
cells from the labeled region of the retina, and they can be
followed to the optic nerve head as they exit from the retina.
DiI tracing of axons in the retinas of BmprIb and wild type
mice revealed defects in the axon pathfinding of the ventrally
located ganglion cells. Fig. 3A and B shows typical examples
of the retinal ganglion cell axon labeling results in a wild type
mouse. The axons remain well bundled as they enter the optic
nerve head (B, arrow). By contrast, in all of the BmprIb/
animals we examined, we found defects in the entry of the
axons into the optic nerve head. In a similar study of EphB2-
and EphB3-deficient mice, Birgbauer et al. (2000) found sim-
ilar defects and classified them into two types based on their
severity. Defects were classified as type 1 if several aberrantly
growing RGC axons were found, and were classified as type 2
if only one or two aberrant fibers were found in a DiI-labeled
bundle. Comparing our results with theirs, 100% of the Bm-
prIb-deficient mice had the more severe type 1 defects (Fig.
3C–F). Typically, within every labeled bundle, there were
many fibers that did not enter the optic nerve head, but rather
made abrupt turns, at times at 90° (e.g., Fig. 3E). These defects
were only observed from labeling ganglion cells in the ventral
retina; labeled bundles of dorsal axons were indistinguishable
from those of wild type animals. Thus, the loss of the BmprIb
gene results in a misrouting of axons from ganglion cells
located in the ventral retina. This may represent a specific
subpopulation of ganglion cells, since most axons did not show
this defect. Alternatively, redundant mechanisms may allow
the majority of ganglion cells to make the correct choices
despite the loss of the BmprIb gene.
Fig. 2. Bmp4 and Bmpr expression in the eye during postnatal develop-
ment. (A–D) Low power views of retinal sections from ages shown. (A, B)
Dorsal (upper) and ventral (lower) fields of retinal sections from postnatal
mice. Bmp4 is highly expressed in the ciliary body (CB). By P7, Bmp4 is
expressed in the inner retinal neurons, presumably amacrine and ganglion
cells. (C, D) BmprIb retains the predominantly ventral pattern of expres-
sion at P0, but by P7, there is a band of expression in the inner nuclear layer
(arrows). (E) At P7, Bmp4 is expressed in both the ganglion cell layer and
the amacrine cell layer of the INL. (G) At postnatal day 7, BmprII is
expressed in the ganglion and amacrine cell layers and in a band of
expression through the inner nuclear layer that partly overlaps with the
BmprIb expression.
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To further investigate the mechanism that might be in-
volved in the misrouting of ventral ganglion cell axons at
the optic nerve head, we analyzed the expression of several
genes known to be involved in axonal targeting and retinal
patterning, using RT-PCR from retinal RNA of P0 wild type
and BmprIb-deficient mice. For this analysis, the entire
retina was dissected from all extraocular tissue, and the
RNA was isolated as described in Materials and methods.
Three basic classes of genes were analyzed: (1) genes
known to be involved in dorsal–ventral patterning of the
retinal axis, such as Vax2, Tbx5, and Pax6; (2) genes known
to be important in retinal progenitor proliferation and the
initial stages of ganglion cell differentiation, such as
FGF15, Chx10, and Math5; and (3) genes previously shown
to be involved in axon targeting of retinal ganglion cells,
such as netrin, Slit, Brn 3b, and several ephrins and Eph
receptors. All of these genes have previously been shown to
be expressed in developing retina (see Discussion for ref-
erences). The RT-PCR analysis is shown in Fig. 4. Of all the
ephrins and Eph receptors that we examined, only Ephrin
A2 was noticeably reduced in expression in the BmprIb/
mice (top panel). However, several other types of genes
related to axonal guidance in retinal ganglion cells were also
reduced in the mutant retina, including Brn3b, netrin, and
Zic2 (Fig. 4, middle panel). Each of these four genes has
been previously implicated in axonal growth in the devel-
oping retina, and the reduction in their expression might be
responsible for the misrouting of axons at the optic nerve
head that we observe in the knockout mice (see Discussion).
Genes with distinct dorsal–ventral asymmetry, such as Vax2
and Tbx5, were not substantially different between the mu-
tant and wild type retinas. In addition, the genes involved in
retinal progenitor proliferation and initial stages of ganglion
cell differentiation—Chx10, FGF15, and Math5—were also
similar in mutant and wild type retinas. Our data from the
PCR analysis are thus consistent with the hypothesis that the
primary defects in the BmprIb/ mice are in genes related
to the process of axon guidance.
In previous studies, more general defects in development
of the ventral retina have been noted when BMP signaling
has been experimentally disrupted (e.g., Adler and Belecky-
Adams, 2002). It is possible that the defects we observed in
axon guidance at the optic nerve head represented a more
general defect in the development of the dorsal–ventral axis
of the retina. We therefore examined the retinas of BmprIb-
deficient animals for gross defects in retinal pattern. In
general, the retina appears qualitatively normal in the knockout
mice. We compared postnatal day 7 wild type retinas with
BmprIb-deficient animals, using immunohistochemistry for a
variety of different retinal-specific antigens (Fig. 5), to deter-
mine whether there were any obvious differences. Fig. 5 shows
the results of the labeling studies using a panel of seven
different antibodies known to be expressed in subtypes of
retinal neurons and glia. From these labeling experiments, we
were unable to detect qualitative differences in any of the
major classes of retinal cells, in either the dorsal or ventral
retina. In addition, we used flatmounts of postnatal retinas to
analyze the distribution of cone photoreceptor subtypes,
known to have dorsoventral gradients in their expression in the
mouse. Again, we found no differences between the BmprIb-
deficient animals and the wild type animals (data not shown).
Thus, we conclude that the defects in axon guidance of the
ventral ganglion cells are not the result of a widespread dis-
ruption of ventral retinal identity or specification, but rather are
specific for ganglion cell axon growth.
BMPR1b-deficient mice show an increase in retinal
apoptosis
In addition to their roles in axon guidance and dorsoventral
patterning, BMPs have also been implicated in the regulation
of apoptosis in the developing nervous system (Smith and
Graham, 2001; Trousse et al., 2001). We therefore analyzed
whether the loss of the BmprIb had any effect on the level of
apoptosis in the developing retina. We examined the retinas
from BmprIb/ animals for evidence of apoptotic cells using
the TUNEL method. We found a greatly increased level of
apoptosis in the retinas of the BmprIb-deficient mice over their
wild type littermates at postnatal day 7. Sections from wild
type and knockout retinas are shown in Fig. 6A–C and D–F,
respectively. The number of labeled cells is elevated in all
regions of the retina in the knockout animals (A, D, dorsal; B,
E, central; C, F, ventral). The apoptotic cells are concentrated
in the inner nuclear layer (arrows) in the knockout retinas, but
are more widely distributed in the wild type retinas. The data
from all animals are quantified and expressed in Fig. 7A. There
is nearly a threefold increase overall.
In an attempt to determine which cells in the developing
INL might be undergoing increased apoptosis in the BmprIb-
deficient animals, we used two different methods. We used
double-label immunohistochemistry to characterize the dying
cells. Fig. 8 shows the results of these studies. While we only
rarely observed apoptotic cells that were labeled for recoverin,
PKC, or Hu, many of the TUNEL-positive cells were also
labeled with Chx10. This marker is expressed in the nuclei of
both bipolar cells and retinal progenitors, and since postnatal
day 7 is approximately the end of retinal histogenesis, it is
possible that the dying cells are the few remaining mitotic
progenitors in the retina. We therefore labeled retinal sections
form both wild type and mutant animals with the mitotic
marker, phospho-histone 3. Fig. 7B shows the quantitation of
these studies. We found no difference between the wild type
and the BmprIb-deficient animals in the number of mitotic cells
at P7. Therefore, the increase in the number of apoptotic cells
in the mutant does not reflect a selective or premature loss in
the progenitor population.
Discussion
The results presented in this report lead to three main
conclusions. First, BMP receptors Ia, Ib, and II are ex-
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pressed in the developing retina. Of the three, BmprIb has
the most striking gradient of expression, with high ven-
tral expression and much lower dorsal expression during
embryonic development, shifting to a more uniform ex-
pression along this axis in the first postnatal week. Sec-
ond, BmprIb-deficient mice have defects in pathfinding of
retinal ganglion cell axons that originate from ventral
cells, though the targeting of the axons from the dorsal
retinal ganglion cells to the optic nerve head is normal.
Third, BmprIb-deficient mice have increased numbers of
apoptotic cells in the inner nuclear layer at postnatal day
7, at the end of retinal histogenesis.
Expression of BMPs and their receptors
BmprIb (ALK6) and BmprIa (ALK3) were first noted to
be expressed in the embryonic eye in the mouse by Dewulf
et al. (1995). In that report, ALK6 was shown to be ex-
pressed in the retina and the optic stalk at embryonic day
12.5. Our report confirms and extends this result, demon-
Fig. 3. BmprIb-deficient mice have defects in ganglion cell axon targeting to the optic nerve head. Small groups of axons are labeled with DiI in flatmounted
retinas. (A, B) Low and high power magnification micrographs of wild type retinas. Axons in wild type retinas grow directly to the optic nerve head (arrow
in B) and rarely make errors. (C–F) By contrast, axons from ventral retina in BmprIb-deficient mice make frequent errors at the optic nerve head. Misrouted
axons were present in every knock-out retina examined (arrows point to misrouted fibers).
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strating that the receptor is expressed almost exclusively in
the ventral hemiretina. This previous report also found
ALK3 (BmprIa) expressed in the embryonic retina, though
no specific pattern was described. We did not detect any
gradient in the level of expression of either BmprIa or
BmprII, at any stage of retinal development. While these
receptors are now known to bind many different BMPs and
related ligands, we have concentrated our analysis on Bmp4
and Bmp7, two factors previously shown to be important in
eye development. We have found that, at early stages of
development, the genes encoding these proteins are ex-
pressed throughout the optic vesicle, while at later stages of
embryonic development, Bmp4 is expressed in the retinal
ganglion cells. Since the BmprIb receptor is primarily lo-
calized to the progenitor cells, it is possible that the ganglion
cells are signaling in a paracrine manner to the progenitor
cells in the embryonic retina.
In the postnatal retina, there are significant changes in the
BMP and receptor expression pattern. Most importantly, the
BmprIb shifts from a nearly exclusive ventral domain of
expression to a uniform pattern of expression in the inner
nuclear layer. During this first postnatal week, the BmprII is
also expressed in the INL, and it is likely that these core-
ceptors are expressed in the same cells. Again, Bmp4 is
expressed in differentiating inner retinal neurons, such as
amacrine cells and ganglion cells. There is thus the potential
for a paracrine signal to the progenitor cells.
There are many similarities in the patterns of expression
of these receptors and ligands in the mouse and the expres-
sion patterns recently reported in the chick. Belecky-Adams
and Adler (2001) have shown that the chick homolog to
BmprIb, BRK-2, is expressed with the same ventral-to-
dorsal gradient as that of the mouse, and moreover is local-
ized to the progenitor zone. As in mouse, the chick BRK-2
receptor appears to lose this dorsal–ventral gradient near the
end of retinal histogenesis, and by E18, is expressed in the
middle of the INL with no regional differences. Also as in
the mouse, the other BRKs in the chick show a less graded
distribution. Belecky-Adams and Adler (2001) also ana-
lyzed the expression of several BMPs, and they found that
BMP7 is concentrated in the inner retinal neurons in the
chick in a pattern very similar to that which we have found
for BMP4 in the postnatal mouse.
BMPs and their receptors and ganglion cell axon
guidance
We have found that the BmprIb-deficient mice have a
defect in axonal pathfinding, such that a number of ventral
ganglion cell axons are misrouted at the optic nerve head.
This result, along with our data showing the distinct BmprIb
gradient of expression along the dorsal–ventral axis of the
retina, supports a role for BMP signaling in dorsal–ventral
retinal identity. Several lines of evidence have previously
implicated BMPs in the regulation of regional identity in the
developing retina. Studies have shown that BMP4 has a
highly restricted domain of expression in the dorsal retina
(Trousse et al., 2001). Misexpression studies have shown
Fig. 4. A comparison of RT-PCR of 20 different genes in wild type () and BmprIb-deficient () mouse retinas. The primer pairs used are listed in Table
1. A small arrowhead points to the expected product in each pair. The genes downregulated in the BmprIb retinas are marked by an asterisk.
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that BMP4 upregulates the expression of another dorsal-
specific gene, Tbx5, and concomitantly represses cVax2 in
the embryonic chick eye (Koshiba-Takeuchi et al., 2000).
Recent studies of the BMP antagonist, ventroptin, lend
further support to the hypothesis that BMPs are critical
regulators of the dorsal–ventral axis of the retina (Sakuta et
al., 2001). Ventroptin misexpression disrupts normal axon
pathfinding to appropriate termination zones in the optic
tectum, at least in part by disrupting the normal expression
pattern of Tbx5 and cVax2. In chick, ectopic expression of
Vax2 leads to ventralization of the early retina, as assayed
by expression of the transcription factors Pax2 and Tbx5,
and the Eph family members EphB2, EphB3, ephrinB1, and
ephrinB2 (Barbieri et al., 2002; Schulte et al., 1999). Vax2-
deficient mice, for example, have defects in ventral retinal
development (Mui et al., 2002) and axonal growth from the
ventral retina (Barbieri et al., 2002). These mice have a loss
of the ipsi-laterally projecting axons that arise from the
ventral retina.
Despite previous evidence that BMP regulates the spec-
ification of the dorsal–ventral axis in the retina, we did not
observe gross defects in overall retinal patterning in the
BmprIb/ mice. For example, there was no difference
between the wild type and BmprIb/ retina in the levels of
Vax2 or Pax6, genes concentrated in the ventral and dorsal
domains, respectively. In addition, examination of other
measures of dorsal–ventral identity, such as the distribution
of S-opsin and M-opsin expressing cone photoreceptors
(data not shown), has failed to reveal any disruption in the
overall patterning of the retina in the BmprIb-deficient mice.
Since the other type I BMP-receptor, BmprIa, is also ex-
pressed in the developing retina, it is possible that many of
the functions of the BMP signaling system can be compen-
sated by use of this alternative receptor. Thus, the axonal
guidance defects we observe in the BmprIb-deficient mice
may be a consequence of the disruption of a more specific
pathway, rather than a general patterning defect.
Consistent with a specific role for BMP signaling in axon
guidance, we found that four genes known to be involved in
axon guidance, EphrinA2, Brn 3b, netrin, and Zic2, had
significantly lower levels of expression in the BmprIb/
mice, as compared with wild type littermate controls. Each
of these genes has been previously implicated in axon guid-
ance in the visual system, and changes in their expression
are consistent with the axonal guidance phenotypes we have
observed in the BmprIb-deficient mouse retinas. EphrinA2
has been previously shown to be expressed in the retina and
to be critical for targeting of the ganglion cell axons to their
correct terminations in the superior colliculus (Feldheim et
al., 2000; Yates et al., 2001). While normally thought to act
as a guidance molecule for targeting along the nasal–tem-
poral axis, the studies with ventroptin (Sakuta et al., 2001)
revealed a somewhat unexpected alteration in the pattern of
ephrins along the nasal–temporal axis. Overexpression of
Fig. 5. Retinal layers and cell types develop qualitatively normally in BmprIb/ mice. Immunohistochemistry for cell type-specific markers was used to
examine retinal sections from wild type and mutant mice. BmprIb/ mice had apparently normal numbers of rod photoreceptors (rhodopsin), bipolar cells
(PKC and chx10), Muller glia (GLAST), amacrine cells (calretinin and CRABP), and ganglion cells (Hu).
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ventroptin induces the expression of Ephrin A2. Thus, the
alteration in the expression of EphrinA2 in the retina of the
BmprIb/ mice may in part explain the axonal targeting
errors that we have observed.
The misrouting of ganglion cell axons at the optic nerve
head that we have observed in the BmprIb-deficient mice
may also be in part explained by the changes in Brn 3b or
Zic2. Both of these genes have been previously implicated
in axon guidance from the retina, although the specific
phenotypes vary depending on the species and the experi-
mental methods. The reduction in Brn 3b expression in the
Bmpr/ retinas is a potential cause of the phenotype we
observe in ganglion cell guidance at the optic nerve head.
Wang et al. (2002) have found that ganglion cells from Brn
3b/ mice extend axons at a rate slower than those from
wild type animals, and the axons from the mutant ganglion
cells also fail to fasciculate properly with other axons. A
similar analysis by Erkman et al. (2000) also reported gan-
glion cell axon pathfinding defects in Brn 3b/ at several
stages in the pathway, including intraretinal defects. More-
over, misexpression of a dominant negative form of the
UNC-115 homolog, abLIM, in embryonic chick retina
caused the ganglion cell axons to make the same type of
abrupt turns at the optic nerve head as those we have
observed in the BmprIb/ retinas. Changes in Zic2 expres-
sion might also be responsible for the misrouting of gan-
glion cell axons at the optic nerve head in the BmprIb/
mice. Zic2 has been previously implicated in various aspects
of CNS development, with mutations in Zic2 leading to
holoprosencephaly in humans (Brown et al., 1998) and
cerebellar defects in mice (Aruga et al., 2002). Of the three
Zic genes that have been examined in the eye, Zic2 is the
most highly expressed. The expression is highest in the
presumptive ciliary body, with a lower level of expression
throughout the progenitor zone at 13.5. Recently, E. Her-
erra, S. Brown, and C. Mason (personal communication)
have implicated Zic2 in the guidance of axons from the
ipsilaterally projecting ganglion cells in the ventral–tempo-
ral retina.
The loss of BmprIb signaling in the ventral retina also
resulted in changes in netrin, another axon guidance mole-
cule. Netrin has been shown to be critical for axonal guid-
ance at various points in the visual system (Deiner et al.,
1997; Deiner and Sretavan, 1999). Mice lacking either ne-
trin or the netrin receptor, DCC, also show axon guidance
defects at the optic nerve head. However, these defects are
much more severe than those observed in the BmprIb/
retinas. This may be due to the fact that, in the netrin-
deficient mice, axons from ganglion cells located through-
out the retina are misrouted, whereas the loss of BmprIb
affects only the axons of ventrally located ganglion cells.
Our results showing a change in netrin expression with the
Fig. 6. BmprIb/ mice show an increase in the number of apoptotic cells in the INL at P7. Micrographs of dorsal (A, D), central, (B, E), and ventral (C,
F) retina of wild type (A–C) and mutant (D–F) P7 mice. In the wild type retinas, there are scattered apoptotic cells in the INL, ONL, and ganglion cell layer.
There are many more apoptotic cells in the INL (arrows) of the BmprIb/ mouse retinas than in the wild type retinas
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loss of the BmprIb gene are also consistent with the recent
report in chick embryos, in which ectopic expression of
noggin, a BMP antagonist, causes a disruption of the ventral
retina and optic stalk, including an expansion of the domain
of netrin expression from the optic stalk to the ventral retina
(Adler and Belecky-Adams, 2002).
Several other genes involved in the dorsal–ventral pat-
terning of the retina might also be involved in the axonal
guidance defect that we have observed. Sonic Hedgehog has
been shown to be important in both dorsal–ventral pattern-
ing of the retina (Huh et al., 1999; Nasrallah and Golden,
2001; Zhang and Yang, 2001) and more recently in directly
regulating the growth of retinal ganglion cell axons (Marti
and Bovolenta, 2002). Since Shh is specifically expressed in
the optic stalk during ocular embryogenesis, and has been
shown to interact with Bmp signaling, it is a good candidate
for future studies.
The overall changes in several critical axon guidance mol-
ecules that result from the reduction in BMP signaling that
presumably accompanies the loss of the BmprIb suggest that
there is a coordinate regulation of these molecules. As noted
above, the changes in the guidance molecules are specific,
without gross changes in the overall dorsal–ventral pattern of
the retina. Thus, our results suggest that BMPs may be impor-
tant at two levels: the overall patterning of the dorsal–ventral
axis, and the regulation of a set of axon guidance molecules
required for ventral ganglion cell axon targeting.
BMP receptors and apoptosis in the retina
We have found that BmprIb-deficient mice have in-
creased numbers of apoptotic cells in the inner nuclear layer
at postnatal day 7, at the end of retinal histogenesis. The
majority of these cells are located in the part of the inner
nuclear layer that contains the chx10 immunoreactive cells
at this age. This protein is present in both retinal progenitor
cells and in the bipolar cells, and since both cell types are
present at postnatal day 7, it is difficult to determine which
cell class is undergoing apoptosis in the BmprIb/ mice.
Other bipolar markers, such as PKC, do not colabel with the
TUNEL-positive cells, but it is possible that a specific
subtype of bipolar cells is affected. Alternatively, the last
progenitor cells are likely to be undergoing their differen-
tiation at this time in development, and it is possible that
loss of BMP signaling results in a failure of their correct
differentiation and subsequent apoptotic death. This possi-
bility is consistent with a recent report demonstrating that
expression of constitutively active BmprIb in neural pro-
genitors in the CNS causes embryonic lethality and gross
abnormalities of the neural tube. Prior to E12, the activated
receptor causes an increase in apoptosis, while after this
time, the embryos show premature neuronal differentiation
of the progenitor cells (Panchision et al., 2001). The authors
conclude that BMPRIb “mediates a generic terminal re-
sponse by causing cell cycle arrest, leading to apoptosis or
differentiation.”
BMPs have also been previously implicated in apoptosis
in the developing eye. Trousse et al. (2001), for example,
found that the timing and position of BMP4 in the chick
embryo correlated with a developmental peak in cell death
in the dorsal retina. They went on to show that the addition
of BMP4 increased the number of apoptotic cells in the
developing chick retina and treatment with BMP antago-
nists reduced apoptosis in the chick retina. Our results
showing an increase in the number of apoptotic cells in the
BmprIb-deficient mouse seem to contradict the results from
the chick. This difference in our results may be due to a
species difference, since Trousse et al. (2001) found that the
apoptotic cells in the embryonic mouse eye were not present
in the retina, as they were in the chick, but were primarily
located in the extraocular tissue. Thus, BMP may not have
a role in the regulation of embryonic retinal cell survival in
the mouse. Alternatively, the loss of the BMP receptor in
the BmprIb-deficient mice may have resulted in a decrease
in the number of apoptotic cells in the mouse eye, but
apoptotic cells in the mouse retina are cleared too rapidly to
be detected with TUNEL. These may in fact be the cells that
we detect later in postnatal retinas as excess cells are lost at
Fig. 7. BmprIb/ mice show an increase in the number of apoptotic cells
(A) but not mitotic (phospho-histone 3) cells (B) in the P7 retina. Mean and
standard deviation are shown for all animals.
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the end of histogenesis. However, another possibility is that
BMP signaling can regulate apoptosis both positively and
negatively. There are reports from other tissues and other
regions of the developing nervous system where BMPs
can be proapoptotic and can act as cell survival factors.
BMPs and eye development
The severe ocular phenotype in BMP7 knockout animals
(Dudley et al., 1995; Jena et al., 1997; Luo et al., 1995) has
to date precluded a more detailed elucidation of the role of
the BMP signaling system in other aspects of retinal devel-
opment, such as the dorsal–ventral patterning of the retina.
Examination of receptor mutants has allowed us to identify
new roles for BMP signaling in the eye. The data from our
analysis, taken together with that of other studies, clearly
show a role for BMP signaling in the dorsal–ventral pat-
terning of the mammalian retina. Moreover, the regulation
of apoptosis by these factors appears to be important to the
last stages of histogenesis in the CNS.
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